In France, despite a high rate of pneumococcal conjugate vaccine coverage, the number of cases of pneumococcal meningitis in children did not decline significantly between 2001–2002 (n = 264) and 2007–2008 (n = 244). A decline was observed among children <2 years old (185 [70.1%] to 134 [54.9%] cases; P = 0.0004), but was counterbalanced by an increase among children ≥2 years old (79 [29.9%] to 110 [45.1%] cases). Mean age increased significantly, from 2.3 (median 0.8) to 3.8 (median 1.5) years. After pneumococcal conjugate vaccine 7 implementation, a wide diversity of serotypes implicated in pneumococcal meningitis was observed; serotypes 19A and 7F were the most frequent.
From the *GPIP (Groupe de Pathologie Infectieuse Pédiatrique) de la SFP (Société Française de Pédiatrie), Paris, France; †ACTIV (Association Clinique et Thérapeutique Infantile du Val de Marne), Paris, France; ‡HEGP (Hôpital Européen Georges Pompidou), Centre National de Référence des Pneumocoques, Paris, France; §Service de Microbiologie, Hôpital Robert-Debré (AP-HP), Université Denis-Diderot, Paris 7, Paris, France; and ¶Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Accepted for publication July 30, 2010.
Supported by the Pediatric Infectious Diseases Group of the French Pediatrics Society (GPIP) and Association Clinique et Therapeutique Infantile du Val de Marne (ACTIV).
The authors have no conflicts of interest to declare.
Address for correspondence: Corinne Levy, MD, ACTIV (Association Clinique et Thérapeutique Infantile du Val de Marne), 27 rue Inkermann, F94100 Saint Maur des Fossés, France. E-mail: firstname.lastname@example.org or email@example.com.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.pidj.com).